The number of adults eligible for GLP-1 drugs may vary by additional requirements employer plans set In setting their coverage requirements, employers will weigh the cost of these drugs against the clinical benefits and demands from their workers and may impose additional eligibility conditions for prescription drug coverage
On its website, the company points to a study that found people taking 1 milligram of semaglutide, less than half of the maximum dose, lost an average of 16% of their body weight over 64 weeks
When people think about exercise for weight loss, they often default to cardio
Not asking if they are okay every time they push a plate away
References: Novo Nordisk A/S: Wegovy pill approved in the US as first oral GLP-1 for weight management - ( Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity - ( Phase 3 Data Support Oral Orforglipron for Weight Maintenance After GLP-1Based Weight Loss - ( Source-Medindia
Also, strategic collaborations, clinical trials, and higher spending on metabolic disorder research keep backing long-term expansion and further technological advancement inside the market
